These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4441828)

  • 1. Propranolol in the control of schizophrenic symptoms.
    Yorkston NJ; Zaki SA; Malik MK; Morrison RC; Havard CW
    Br Med J; 1974 Dec; 4(5945):633-5. PubMed ID: 4441828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safeguards in the treatment of schizophrenia with propranolol.
    Yorkston NJ; Zaki SA; Themen JF; Havard CW
    Postgrad Med J; 1976; 52 Suppl 4():175-80. PubMed ID: 967774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol as an adjunct to the treatment of schizophrenia.
    Yorkston NJ; Zaki SA; Pitcher DR; Gruzelier JH; Hollander D; Sergeant HG
    Lancet; 1977 Sep; 2(8038):575-8. PubMed ID: 71397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in schizophrenia.
    Sethi BB; Dubé S
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):89-99. PubMed ID: 6682990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.
    Yorkston NJ; Zaki SA; Weller MP; Gruzelier JH; Hirsch SR
    Acta Psychiatr Scand; 1981 Jan; 63(1):13-27. PubMed ID: 7015789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual hallucinations and propranolol.
    Shopsin B; Hirsch J; Gershon S
    Biol Psychiatry; 1975 Feb; 10(1):105-7. PubMed ID: 1120173
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose propranolol in schizophrenia.
    Sheppard GP
    Br J Psychiatry; 1979 May; 134():470-6. PubMed ID: 476356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion.
    Atsmon A; Blum I; Steiner M; Latz A; Wijsenbeek H
    Psychopharmacologia; 1972; 27(3):249-54. PubMed ID: 4642464
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug for schizophrenia?
    Br Med J; 1974 Dec; 4(5945):614-5. PubMed ID: 4441823
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenergic blockade in the control of schizophrenic symptoms--a case for controlled studies.
    Yorkston N
    Scott Med J; 1975 Nov; 20(6):292-4. PubMed ID: 4892
    [No Abstract]   [Full Text] [Related]  

  • 15. Dextro-propranolol in schizophrenia.
    Hirsch SR; Manchanda R; Weller MP
    Prog Neuropsychopharmacol; 1980; 4(6):633-7. PubMed ID: 7220678
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission of thyrotoxicosis during treatment with propranolol.
    McLarty DG; Brownlie BE; Alexander WD; Papapetrou PD; Horton P
    Br Med J; 1973 May; 2(5862):332-4. PubMed ID: 4122248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
    Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH
    Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged delirium with propanolol.
    Kuhr BM
    J Clin Psychiatry; 1979 Apr; 40(4):198-9. PubMed ID: 33971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dose of propranolol for migraine prophylaxis. Efficacy of low doses.
    Pascual J; Polo JM; Berciano J
    Cephalalgia; 1989 Dec; 9(4):287-91. PubMed ID: 2611887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.